Breaking News, Collaborations & Alliances

leon-nanodrugs Supports Takeda in a Feasibility Assessment

Will utilize proprietary MicroJet Reactor nano-technology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Takeda has chosen leon-nanodrugs’ proprietary MicroJet Reactor (MJR) nano-technology for a feasibility assessment that could potentially lead to the development of an innovative formulation of one of their current pipeline products. leon-nanodrugs said it started a feasibility assessment collaboration with Takeda under which it will support Takeda’s formulation efforts to optimize solubility, bioavailability and stability for one of Takeda’s current pipeline products for dru...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters